Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.

Murphy AJ, Funt S, Gorman D, Tall AR, Wang N.

Circ Res. 2013 Jun 21;113(1):e1-9. doi: 10.1161/CIRCRESAHA.113.301112. Epub 2013 Apr 23.

PMID:
23613182
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice.

Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, Fazio S.

Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1790-5.

PMID:
11701467
[PubMed - indexed for MEDLINE]
Free Article
3.

Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.

Diditchenko S, Gille A, Pragst I, Stadler D, Waelchli M, Hamilton R, Leis A, Wright SD.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2202-11. doi: 10.1161/ATVBAHA.113.301981. Epub 2013 Jul 18.

PMID:
23868939
[PubMed - indexed for MEDLINE]
Free Article
4.

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.

Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM.

Circulation. 2004 Jun 29;109(25):3215-20. Epub 2004 Jun 14.

PMID:
15197147
[PubMed - indexed for MEDLINE]
Free Article
5.

5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

Amar MJ, D'Souza W, Turner S, Demosky S, Sviridov D, Stonik J, Luchoomun J, Voogt J, Hellerstein M, Sviridov D, Remaley AT.

J Pharmacol Exp Ther. 2010 Aug;334(2):634-41. doi: 10.1124/jpet.110.167890. Epub 2010 May 19.

PMID:
20484557
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.

Wang WQ, Moses AS, Francis GA.

Biochemistry. 2001 Mar 27;40(12):3666-73.

PMID:
11297434
[PubMed - indexed for MEDLINE]
7.

Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.

Song G, Tian H, Qin S, Sun X, Yao S, Zong C, Luo Y, Liu J, Yu Y, Sang H, Wang X.

Atherosclerosis. 2012 Mar;221(1):55-65. doi: 10.1016/j.atherosclerosis.2011.11.043. Epub 2011 Dec 13.

PMID:
22209213
[PubMed - indexed for MEDLINE]
8.
9.

A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells.

Yancey PG, Yu H, Linton MF, Fazio S.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1123-31. Epub 2007 Feb 15.

PMID:
17303773
[PubMed - indexed for MEDLINE]
Free Article
10.

Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.

Lee M, Calabresi L, Chiesa G, Franceschini G, Kovanen PT.

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1475-81.

PMID:
12231569
[PubMed - indexed for MEDLINE]
Free Article
11.

Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.

Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A.

Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):516-25. doi: 10.1161/ATVBAHA.113.302407. Epub 2014 Jan 16.

PMID:
24436372
[PubMed - indexed for MEDLINE]
12.

Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice.

Feng Y, Schouteden S, Geenens R, Van Duppen V, Herijgers P, Holvoet P, Van Veldhoven PP, Verfaillie CM.

PLoS One. 2012;7(11):e47286. doi: 10.1371/journal.pone.0047286. Epub 2012 Nov 7.

PMID:
23144813
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.

Hewing B, Parathath S, Barrett T, Chung WK, Astudillo YM, Hamada T, Ramkhelawon B, Tallant TC, Yusufishaq MS, Didonato JA, Huang Y, Buffa J, Berisha SZ, Smith JD, Hazen SL, Fisher EA.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):779-89. doi: 10.1161/ATVBAHA.113.303044. Epub 2014 Jan 9.

PMID:
24407029
[PubMed - indexed for MEDLINE]
14.

Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.

Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF.

Circulation. 2003 Nov 4;108(18):2258-63. Epub 2003 Oct 27.

PMID:
14581413
[PubMed - indexed for MEDLINE]
Free Article
15.

Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.

Umemoto T, Han CY, Mitra P, Averill MM, Tang C, Goodspeed L, Omer M, Subramanian S, Wang S, Den Hartigh LJ, Wei H, Kim EJ, Kim J, O'Brien KD, Chait A.

Circ Res. 2013 May 10;112(10):1345-54. doi: 10.1161/CIRCRESAHA.111.300581. Epub 2013 Mar 15.

PMID:
23501697
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.

Nogi Y, Nagashima M, Terasaki M, Nohtomi K, Watanabe T, Hirano T.

PLoS One. 2012;7(4):e35683. doi: 10.1371/journal.pone.0035683. Epub 2012 Apr 20.

PMID:
22536426
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.

Parks BW, Srivastava R, Yu S, Kabarowski JH.

Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):539-47. doi: 10.1161/ATVBAHA.108.179937. Epub 2009 Jan 22.

PMID:
19164809
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin.

Zhang X, Chen B.

Cancer Lett. 2010 Dec 1;298(1):26-33. doi: 10.1016/j.canlet.2010.05.023. Epub 2010 Jun 25.

PMID:
20579804
[PubMed - indexed for MEDLINE]
19.

Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.

Pendse AA, Johnson LA, Kim HS, McNair M, Nipp CT, Wilhelm C, Maeda N.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1436-44. doi: 10.1161/ATVBAHA.112.248682. Epub 2012 Apr 26.

PMID:
22539598
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.

Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH.

Circulation. 2007 May 8;115(18):2442-50. Epub 2007 Apr 16.

PMID:
17438151
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk